Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2018 07:30 ET | Source: Helix BioPharma Corp.

Helix BioPharma Corp. to initiate new L-DOS47 clinical program in pancreatic cancer

RICHMOND HILL, Ontario, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates...
November 01, 2018 07:00 ET | Source: Tetra Bio-Pharma Inc

Tetra Natural Health Signs Exclusive Agreement for the Distribution of their Hemp Energy Drink in Canada and the USA

Tetra Natural Health Looking to Exploit Consumer Appetite for Hemp Based products OTTAWA, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Tetra Natural Health Inc., a division of Tetra Bio-Pharma Inc. (“Tetra”...
November 01, 2018 07:00 ET | Source: ICC International Cannabis Corp.

REPEAT - International Cannabis Unveils Global Distribution Management System

VANCOUVER, British Columbia, Nov. 01, 2018 (GLOBE NEWSWIRE) -- ICC International Cannabis Corp. (CSE: WRLD)(FWB: 8K51)(OTC: KNHBF) ("ICC" or “International Cannabis” or the “Company”) is pleased to...
November 01, 2018 07:00 ET | Source: Flux7

Flux7 Announces Landing Zones For Secure, Scalable AWS Adoption

Highly automated solutions for migrating essential services and production accounts help enterprises start right, scale fast AUSTIN, Texas, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Flux7, a...
November 01, 2018 07:00 ET | Source: NuCana plc

NuCana Announces First Patients Enrolled in Phase Ib Study of NUC-3373 in Advanced Colorectal Cancer

NuTide:302 Study Will Evaluate NUC-3373 in Combination with Other Agents Typically Administered with 5-FU EDINBURGH, United Kingdom, Nov. 01, 2018 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA)...
November 01, 2018 07:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals Receives FDA Fast Track Designation for CPI-0610 in Treatment of Myelofibrosis

- Recently Expanded and Enhanced MANIFEST Phase 2 Trial Ongoing with Proof of Concept Data Expected Mid-2019 CAMBRIDGE, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals,...
November 01, 2018 06:45 ET | Source: GW Pharmaceuticals plc

EPIDIOLEX® (cannabidiol) Oral Solution – the First FDA-approved Plant-derived Cannabinoid Medicine – Now Available by Prescription in the U.S.

- Medication indicated for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome, two rare, severe childhood-onset epilepsies - - Comprehensive support program...
November 01, 2018 06:00 ET | Source: INSYS Therapeutics, Inc.

INSYS Therapeutics Announces Results of PK Study Assessing Proprietary Intranasal Naloxone Formulations versus Intramuscular and Intravenous Naloxone for Opioid Overdose

PHOENIX, Nov. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), today announced that a pharmacokinetic (PK) study (INS012-18-119) of its proprietary intranasal naloxone spray...
November 01, 2018 05:00 ET | Source: Envision Solar International, Inc.

Envision Solar Announces the Delivery of EV ARC™ Products to the California Department of Fish and Wildlife

SAN DIEGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Envision Solar International, Inc. (QTCQB: EVSI), the leading producer of unique and sustainable infrastructure products for electric vehicle charging,...
November 01, 2018 03:00 ET | Source: ChildCare Education Institute

ChildCare Education Institute Offers No-Cost Online Course on Addressing Homelessness: The Role of the Early Childhood Educator

Duluth, GA, Nov. 01, 2018 (GLOBE NEWSWIRE) -- ChildCare Education Institute® (CCEI), an online child care training provider dedicated exclusively to the early care and education workforce, offers...